SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group (CAR) is currently experiencing extreme volatility driven by a massive, supply-constrained short squeeze that has captivated the trading community. Investors are actively debating whether this parabolic move is a sustained mechanical phenomenon controlled by major stakeholders or a high-risk bubble nearing an inevitable and violent exhaustion.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is experiencing intense volatility and social media attention as traders debate whether its recent surge is a sustainable breakout driven by its role in AI data center power infrastructure or a speculative bubble destined for a reversal. The community remains sharply divided, with bulls pointing to the company's strategic partnerships and GaN technology advancements, while bears argue the valuation is detached from current revenue and profitability.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bear 3X ETF

Direxion Daily Semiconductor Bear 3X Shares

Investors are intensely debating whether the semiconductor sector is currently in a historic blow-off top or a sustained rally, with many expressing frustration over the persistent daily declines in this inverse ETF despite sector volatility. The community is deeply divided between those capitulating on their positions due to extreme exhaustion and those aggressively averaging down, pinning their hopes on an impending earnings-driven market correction or a significant technical reversal.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is rallying on massive volume as investors react to CFO Thomas Mikas comments confirming production orders from hyperscalers and key partnerships that validate the company's optical engine technology. The community is actively dismissing recent short-seller reports and expressing high conviction, with sentiment bolstered by bullish option activity and excitement over the potential for the stock to scale alongside the AI infrastructure buildout.

Kyverna Therapeutics, Inc. is a cell therapy clinical-stage biotechnology company, which engages in the provision of treatments and potential cures for serious autoimmune diseases. The company was founded in June 2018 and is headquartered in Emeryville, CA.

Kyverna Therapeutics Inc.

Kyverna Therapeutics is surging after reporting positive registrational trial data for its CAR-T therapy, miv-cel, in treating Stiff Person Syndrome, showing statistically significant improvements in mobility and independence. The community is actively discussing the stock's potential for FDA approval by early 2026, comparing its efficacy against competitors, and speculating on its status as a prime acquisition target for larger pharmaceutical firms.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is trending as investors react to a significant price target increase from Stifel and surging interest in its role within the AI infrastructure expansion. The community remains deeply divided, with bulls pointing to the company's competitive standing against NVIDIA and long-term hyperscaler demand, while cautious traders are debating whether the recent momentum is overextended and susceptible to broader geopolitical volatility.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

Direxion Daily Semiconductor Bull 3X Shares (SOXL) is experiencing extreme volatility and a parabolic rally driven by intense speculative momentum and persistent short-covering as the semiconductor sector continues to reach new highs. The community is sharply divided, with bulls celebrating life-changing gains and betting on further upside, while bears warn of a speculative bubble, significant leverage decay, and the high risks associated with holding a 3x leveraged product in an overextended market.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

Sellas Life Sciences is currently trending as investors focus on an upcoming poster presentation of its CDK9 inhibitor, SLS009, at the American Association for Cancer Research (AACR) meeting. The community remains deeply divided, with bulls pointing to the drug's potency and potential acquisition value, while bears emphasize frustrations over trial timelines and skepticism regarding the company's historical performance.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch is capturing attention as the community rallies around its unique passive income model, which automatically distributes Solana rewards to holders every six hours. Investors are actively discussing the project's resilience, recent technical developments, and the long-term utility of its reward-generating mechanism.

OpenGradient

OpenGradient is gaining significant momentum as investors rotate capital from other speculative assets, with the community actively highlighting its early-stage potential and high-volume trading activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Microbot Medical Begins Full U.S. Launch of LIBERTY System

MBOT moves to full U.S. launch of its LIBERTY robotic system after strong hospital adoption, boosting momentum for faster market uptake and sales growth.

Microbot Medical's (MBOT) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright restated a "buy" rating and issued a $12.00 target price on shares of Microbot Medical in a report on Tuesday...

Microbot Medical (NASDAQ:MBOT) Shares Pass Above 200-Day Moving Average - Time to Sell?

Microbot Medical (NASDAQ:MBOT) Stock Passes Above 200-Day Moving Average - Should You Sell...

Microbot Medical Inc. (NASDAQ:MBOT) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report) have been given an average rating of "Moderate Buy" by the five research firms that are currently covering the firm, MarketBeat...

Microbot Medical (NASDAQ:MBOT) Announces Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Microbot Medical (NASDAQ:MBOT - Get Free Report) posted its quarterly earnings results on Thursday. The biotechnology company reported ($0.04) EPS for the quarter, topping analysts' consensus...

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value

MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value MedTech's Edge: How AI and Remote Diagnostics Drive Scalable Value PR Newswire VANCOUVER, BC, March 27, 2026 Issued on behalf of...

Microbot Medical Inc. $MBOT Shares Purchased by CIBC Private Wealth Group LLC

CIBC Private Wealth Group LLC raised its position in Microbot Medical Inc. (NASDAQ:MBOT - Free Report) by 137.6% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,454,000 shares of the biotechnology company's stock aft...

Heights Capital Management Inc. Buys New Stake in Microbot Medical Inc. $MBOT

Heights Capital Management Inc. bought a new stake in shares of Microbot Medical Inc. (NASDAQ:MBOT - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with...

Microbot Medical (NASDAQ:MBOT) Stock Price Crosses Above 200-Day Moving Average - Here's What Happened

Microbot Medical (NASDAQ:MBOT) Shares Cross Above Two Hundred Day Moving Average - Here's Why...

Microbot Medical (MBOT) to Release Earnings on Tuesday

Microbot Medical (NASDAQ:MBOT) will be releasing earnings before the market opens on Tuesday, March 24. (View Earnings Report at...

Microbot Medical, Inc. is a medical device company, which engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. It carries out its operations through the ViRob and TipCat platforms. The ViRob platform technology is an autonomous crawling micro-robot that can be controlled remotely or within the body. It makes use of the Self-Cleaning Shunt, a robotic system designed as the ventricular catheter portion of a Cerebrospinal Fluid shunt system and is mainly used for the treatment of hydrocephalus and Normal Pressure Hydrocephalus. The TipCat platform, a self-propelling, flexible, and semi-disposable endoscope, provides see-and-treat capabilities within tubular lumens in the human body such as the colon, blood vessels, and the urinary tract. The company was founded by Harel Gadot, Moshe Shoham, and Yosseph Bornstein on August 2, 1988 and is headquartered in Hingham, MA.

MBOT
Microbot Medical Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MBOT News

MBOTMicrobot Medical Inc